Emcure Pharmaceuticals Ltd (EMCURE) — Cash Flow Quality Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Cash Flow Quality Index of 0.57x as of September 2025. Operating cash flow of Rs2.56 Billion is below net income of Rs4.50 Billion, suggesting accrual-heavy earnings not yet converted to cash. Also explore Emcure Pharmaceuticals Ltd asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Emcure Pharmaceuticals Ltd Cash Flow Quality Index (2022–2026)
Historical Cash Flow Quality Index for Emcure Pharmaceuticals Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Emcure Pharmaceuticals Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year earnings quality comparison for Emcure Pharmaceuticals Ltd. For live market cap and the full company financial profile, see EMCURE stock market capitalisation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 0.92x | Rs8.51 Billion | Rs9.24 Billion | ▲ +4.9% |
| 2025 | 0.88x | Rs8.52 Billion | Rs9.71 Billion | ▼ -60.2% |
| 2024 | 2.20x | Rs10.97 Billion | Rs4.98 Billion | ▲ +56.9% |
| 2023 | 1.40x | Rs7.47 Billion | Rs5.32 Billion | ▲ +21.0% |
| 2022 | 1.16x | Rs7.68 Billion | Rs6.62 Billion | — |